• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Cancer vaccine prompts robust immune response

The vaccine combines NY-ESO-1 with IMX, a potent immune-system stimulator that consists of cholesterol, phospholipids and saponin.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Study Highlights Image-Guided Superficial Radiation Therapy as a Viable First-Line Treatment for Nonmelanoma Skin Cancer
February 6th 2025

Study Highlights Image-Guided Superficial Radiation Therapy as a Viable First-Line Treatment for Nonmelanoma Skin Cancer

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Matthew Zirwas, MD, Previews South Beach Symposium
February 5th 2025

Matthew Zirwas, MD, Previews South Beach Symposium

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Reviewing Complex Cases: Disruptive AD
February 5th 2025

Reviewing Complex Cases: Disruptive AD

CRYSTAL Real-World Study Explores State and Severity of Psoriasis in Greece
February 5th 2025

CRYSTAL Real-World Study Explores State and Severity of Psoriasis in Greece

© 2025 MJH Life Sciences

All rights reserved.